PharmaQo Arimidex 1 – 1 mg Anastrozole Oral Tablets (50 Tablets)

Customer Review 0
5/5

£ 17.00

PharmaQo Arimidex 1 is a 50-tablet pack of 1 mg Anastrozole oral tablets designed strictly for research and investigational use. Anastrozole is an aromatase inhibitor studied for its potential to reduce estrogen synthesis, primarily in hormone-sensitive research models involving breast cancer, hormone regulation, and related endocrine pathways. This product is not approved for human consumption and should be used only under controlled research protocols.

Quantity Discounts

QuantityPrice
0 - 49£ 17.00
50 - 99£ 15.30
100 - 249£ 14.45
250 +£ 13.60
Share it :
Payment-Icon.png
International Shipment

Your orders are shipped seamlessly between countries

30 Days Warranty

You have the right to return your orders within 30 days.

Secure Payment

Your payments are secure with our private security network.

Description

PharmaQo Arimidex 1 delivers 1 mg Anastrozole per oral tablet, packaged in 50-tablet packs for research use. Anastrozole is a nonsteroidal aromatase inhibitor under investigation for its role in reducing estrogen production, making it valuable in research on hormone-sensitive cancers, endocrine modulation, and post-cycle estrogen management models.

It is known for effectively lowering circulating estrogen levels without significant androgenic or progestogenic activity.


Product Details:
Active Ingredient:

  • Anastrozole (Arimidex)

Concentration: 1 mg per tablet

Form: Oral tablets

Packaging: 50 tablets per pack


Pharmacokinetics:
Anastrozole has an oral half-life of ~46–48 hours, allowing for once-daily dosing in most research designs.


Usage Recommendations:

  • Indications (Research Context): Investigational use in estrogen suppression, hormone-sensitive tumor models, post-cycle hormone regulation (not approved for human use)

  • Typical Dosage (Research Use): 0.5–1 mg per day, depending on study protocol

  • Monitoring: Estrogen levels, lipid profile, bone density, liver function

  • Cycle/Duration: As determined by research objectives


Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always follow local research regulations and ethical standards.

error: Content is protected !!